Skip to main
SOLV
SOLV logo

Solventum Corporation (SOLV) Stock Forecast & Price Target

Solventum Corporation (SOLV) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 25%
Hold 63%
Sell 0%
Strong Sell 13%

Bulls say

Solventum Corp is poised for significant growth driven by its strategies to enhance market penetration and develop innovative solutions across its segments. The company's focus on accelerating global adoption of its antimicrobial solutions and expanding its capabilities in Revenue Cycle Management is expected to elevate the standard of care and facilitate international growth. Furthermore, continued product innovation and an emphasis on autonomous coding within the company's offerings support a robust revenue outlook, primarily stemming from its MedSurg segment.

Bears say

Solventum Corp has faced a significant decline in volume growth, recording seven consecutive quarters of negative volumes prior to any restructuring efforts, which raises concerns about its operational performance and market demand. Additionally, the company is projected to experience approximately 40 basis points of gross margin declines in 2026, primarily due to the anticipated full-year impact of tariffs, further straining its profitability. These foundational issues suggest ongoing challenges for Solventum, impacting its overall financial health and future growth prospects.

Solventum Corporation (SOLV) has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 25% recommend Buy, 63% suggest Holding, 0% advise Selling, and 13% predict a Strong Sell.

This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Solventum Corporation (SOLV) Forecast

Analysts have given Solventum Corporation (SOLV) a Hold based on their latest research and market trends.

According to 8 analysts, Solventum Corporation (SOLV) has a Hold consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Solventum Corporation (SOLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.